| Home | E-Submission | Sitemap | Contact Us |  

Liem, Suryandari, Malik, Mansyur, Soemarko, Kekalih, Subekti, Suyatna, and Pangaribuan: The Role of CYP2B6*6 Gene Polymorphisms in 3,5,6-Trichloro-2-pyridinol Levels as a Biomarker of Chlorpyrifos Toxicity Among Indonesian Farmers



One of the most widely used pesticides today is chlorpyrifos (CPF). Cytochrome P450 (CYP)2B6, the most prominent catalyst in CPF bioactivation, is highly polymorphic. The objective of our study was to evaluate the role of CYP2B6*6, which contains both 516G>T and 785A>G polymorphisms, in CPF toxicity, as represented by the concentration of 3,5,6-trichloro-2-pyridinol (TCPy), among vegetable farmers in Central Java, Indonesia, where CPF has been commonly used.


A cross-sectional study was conducted among 132 vegetable farmers. Individual socio-demographic and occupational characteristics, as determinants of TCPy levels, were obtained using a structured interviewer-administered questionnaire and subsequently used to estimate the cumulative exposure level (CEL). TCPy levels were detected with liquid chromatography-mass spectrometry. CYP2B6*6 gene polymorphisms were analyzed using a TaqMan® SNP Genotyping Assay and Sanger sequencing. Linear regression analysis was performed to analyze the association between TCPy, as a biomarker of CPF exposure, and its determinants.


The prevalence of CYP2B6*6 polymorphisms was 31% for *1/*1, 51% for *1/*6, and 18% for *6/*6. TCPy concentrations were higher among participants with CYP2B6*1/*1 than among those with *1/*6 or *6/*6 genotypes. CYP2B6*6 gene polymorphisms, smoking, CEL, body mass index, and spraying time were retained in the final linear regression model as determinants of TCPy.


The results suggest that CYP2B6*6 gene polymorphisms may play an important role in influencing susceptibility to CPF exposure. CYP2B6*6 gene polymorphisms together with CEL, smoking habits, body mass index, and spraying time were the determinants of urinary TCPy concentrations, as a biomarker of CPF toxicity.

Graphical abstract


Approximately 33 million Indonesians are farmers, most of whom are small-scale farmers. Among them, pesticide use is very common and occupational exposure is significant. Organophosphates (OPs), of which chlorpyrifos (CPF) accounts for 40%, are among the most commonly used pesticides [1]. Despite the extensive use of pesticides, farmers in the small-scale agricultural sector are often not aware that they are susceptible to the health impacts of CPF exposure. The health impacts reported in previous studies include neurological symptoms, alterations in reproductive hormone levels, and metabolic and endocrine disorders [24]. However, the severity of exposure is also determined by several other factors, such as metabolism in the human body, the type of pesticide, and exposure concentration and duration [5,6].
Human cytochrome P450 (CYP) is known to have important effects related to its role as catalyst for numerous drugs and chemicals, including pesticides, in metabolic reactions [7,8]. Several OPs, including CPF and parathion, are metabolically activated to their oxon form through reactions catalyzed by CYP [9]. CPF in particular can undergo a desulfurization reaction activated by CYP2B6, resulting in the formation of the active metabolite CPF-oxon (CPF-O). Following the bioactivation and detoxification of CPF, a specific metabolite (3,5,6-trichloro-2-pyridinol; TCPy) excreted in urine is formed [9,10]. Therefore, TCPy, which can be used to estimate the internal uptake of CPF, has been used as a biomarker of CPF exposure in several epidemiological studies [11,12].
CYP2B6 is highly polymorphic in terms of expression and enzymatic activity due to the presence of common single-nucleotide polymorphisms (SNPs), and its genetic variants are associated with inter-individual variability [13]. CYP2B6 is the most prominent catalyst of CPF bioactivation. In particular, CYP2B6*6 is expressed at lower levels, thereby reducing its ability to activate CPF-O formation [14]. To date, CYP2B6 polymorphisms have been studied in several different populations, but there are limited data on its distribution among Indonesian population. Furthermore, the role of CYP2B6 gene polymorphisms in pesticide exposure has generally been evaluated in human liver microsomes or animal studies, whereas epidemiological studies focusing on the relationship between susceptibility and exposure biomarkers, especially those emphasizing CPF, are scarce. Therefore, our study aimed to evaluate the role of CYP2B6 gene polymorphisms in CPF toxicity, as represented by the level of TCPy, among vegetable farmers in Central Java, Indonesia, where CPF has been commonly used. We hope that our results will provide valuable information about determinants of CPF exposure, particularly its susceptibility biomarker.


Study Population

We conducted a cross-sectional study, the participants of which came from vegetable farming areas in Central Java, Indonesia. The main products of this area are garlic, shallots, potatoes, chilies, and cabbage. The recruitment process lasted from July to October 2020. This time was chosen as optimal for the assessment of actual exposure, as farmers carry out routine pesticide application during this period. The minimum sample size of our study was determined to be 124 participants, as we used the standard deviation (SD) for urinary TCPy from a previous study (2.97 μg/g creatinine) [15], to achieve 80% power and a 5% significance level (2-tailed), for detecting a significant difference of 1.5 μg/g creatinine in mean TCPy levels between groups. The eligibility criteria were vegetable farmers, male or female, aged 18–65 who have actively used CPF for at least 1 year. A small remuneration was given to the participants for their participation. As the sample frame, there were 195 vegetable farmers who met the eligibility criteria and gave written consent to participate in the study. We decided to take the total sample consecutively.
The study consisted of 2 phases. In the first phase, we obtained participants’ socio-demographic and occupational characteristics through a structured interviewer-administered questionnaire. Twenty participants were considered to have withdrawn from the study because they did not attend the second phase. Among those who attended the second phase and were informed of their general health condition, 24 participants who did not undergo blood sampling for the CYP2B6 genotyping assay or completed the health questionnaire were excluded, leaving only 151 participants. Finally, there were 132 participants whose urine samples were available to test for urinary TCPy (corrected with urinary creatinine) and analyzed in this study.

Occupational Characteristics and Cumulative Exposure Level

Occupational characteristics consisted of several variables related to agricultural activities. The participants used almost no modern technology except for motorized knapsack sprayers during the insecticide application. All pesticide handling and farming activities were done manually.
A validated quantitative approach was used to estimate the cumulative exposure level (CEL) [16]. In brief, pesticide handling activities, personal protective equipment (PPE) utilization, personal hygiene, and spill management practices were identified, then a score was given for each parameter and further used to estimate the daily exposure intensity level (IL). The IL, combined with frequency of annual spraying days and duration (lifetime years) of pesticide use, was used to estimate CEL. For example, the estimated CEL of a participant with a daily IL of 20/day for an average of 100 application day/y (frequency) over 20 years (duration) would be 40 000. The median value was used to classify participants into high-exposure and low-exposure groups, as described previously [17].

CYP2B6*6 Genotyping (516G>T–rs3745274 and 785A>G–rs2279343)

CYP2B6*6 contains both 516G>T and 785A>G polymorphisms. Therefore, the CYP2B6*6 genotype was classified as follows: *1/*1 (GG/AA); *1/*6 (GT/AG); and *6/*6 (TT/GG).
Genotyping was performed by Prodia Clinical Lab (Jakarta, Indonesia). Whole blood samples were drawn from each participant using 3-mL ethylenediaminetetraacetic acid anticoagulant tubes (Vacuette®). Samples were transported to Prodia Clinical Lab and stored at −20°C prior to analysis. Genomic DNA extraction was performed using the spin column method according to the manufacturer’s protocol (Genomic DNA Mini Kit; Geneaid Biotech Ltd., New Taipei City, Taiwan). A NanoDrop One spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA) was used to analyze DNA purity and concentrations. The extracted DNA was stored at −20°C until further use.
The CYP2B6–516G>T polymorphism was analyzed using the TaqMan® SNP Genotyping Assay C___7817765_60 (Applied Biosystems, Foster City, CA, USA) as the primers and probe on a Rotor-Gene Q (Qiagen GmbH, Hilden, Germany) thermocycler. TaqMan GTXpress Master Mix (Applied Biosystems) was used as the master mix of the polymerase chain reaction (PCR) reagent. The laboratory kit was intended for research use only. Genotypes were determined by an allelic discrimination plot using fluorescence signals (FAM and VIC from the TaqMan probe) according to the manufacturer’s instructions (Supplemental Material 1). In addition, 6 samples underwent DNA sequencing to validate the above CYP2B6 516G>T allelic discrimination assay. The PCR product of 533 bp was used for sequencing (Supplemental Material 2). The CYP2B6–785A>G genotype was analyzed using Sanger sequencing. Samples were amplified by PCR with primers as described by Zakeri et al. [18], which produced a 640 bp PCR product for sequencing (Supplemental Material 3). All steps in sequencing were performed by the 1st Base DNA Sequencing Division (Apical Scientific Sdn Bhd, Selangor, Malaysia). Examples of the DNA sequencing results for CYP2B6 516G>T and 785A>G are presented in Supplemental Materials 4 and 5.

Urinary 3,5,6-Trichloro-2-pyridinol

Spot urine samples were collected using a sterile urine container. We obtained the last spraying date to be deducted against the urine collection date to calculate the number of post-spraying days, which was defined as the number of days between the last spraying day and urine collection. Samples were stored in a −20°C freezer until analysis and then analyzed for TCPy levels by Prodia Industrial Toxicology Laboratory. All solvents used in these methods were analytical grade for high-performance liquid chromatography (HPLC) or liquid chromatography tandem mass spectrometry: the analytical standard was 3,5,6-trichloro-2-pyridinol (product No. 33972; batch: BCBZ8746; Sigma-Aldrich, St. Louis, MO, USA); the internal standard was 3,5,6-trichloro-2-pyridinol-4,5,6-13C3-15N (Sigma-Aldrich); and the other materials used were hydrogen chloride, sodium chloride, and acetonitrile (Merck KGaA, Darmstadt, Germany); methanol (Tedia, Fairfield, OH, USA); and formic acid (Kanto Chemical Co., Tokyo, Japan).
Briefly, the extraction procedure was adopted from Smith et al. [19], and the separation and detection procedure was adopted with small adjustments from the CDC 6103.03 laboratory method [20]. Chromatographic separation was performed using Agilent HPLC (Infinity 1260; Santa Clara, CA, USA). Agilent Ultivo triple quadrupole mass spectrometer (Agilent) with Masshunter software program was used for data acquisition and data analysis. The within-run precision for TCPy analysis at 1 ppb was excellent, with a 4.77% relative SD and a standard curve correlation coefficient of 0.998.
Detectable TCPy levels were adjusted by urinary creatinine to reduce intra-individual and inter-individual variability [21,22]. Urinary creatinine was analyzed in a Proline R-910 system using a commercial kit (Proline Creatinine PAP FS; Proline, West Java, Indonesia) for quantitative determination in accordance with standard clinical laboratory methods. The TCPy values were expressed as μg/g creatinine.

Statistical Analysis

The analysis was performed using SPSS version 20 (IBM Corp., Armonk, NY, USA). The study population characteristics were summarized with the frequency distribution for categorical variables, while continuous variables were described using mean±SD or median (minimum–maximum). The chi-square test was used to evaluate the significance of differences in genotype frequencies according to sex and CEL. Allele and genotype frequencies were calculated directly. The Mann-Whitney U test and the Kruskal Wallis test were used to evaluate the significance of differences in TCPy levels. All p-values were two-sided, and p<0.05 was considered the threshold of statistical significance. Age and sex, as individual predictors, together with CYP2B6*6 and CEL, as important occupational factors, were included in the multivariate model together with the variables associated with TCPy at a significance level of p≤0.20 in the simple regression analysis. All determinants associated with TCPy at a significance level of 0.05 were retained in the final stepwise model. Several assumptions were met for the multiple linear regression analysis. There was no multicollinearity in this data, as the variance inflation factor scores were well below 10, and the tolerance scores were above 0.2. The Durbin-Watson statistic showed that the values of the residuals were independent, as the obtained value was very close to 2 in the linear regression model. We also calculated the Cook’s distance values for each participant, and since no values over 1 were found, we suggest that there were no residual outliers biasing our model.

Ethics Statement

The study protocol was approved by the Ethical Committee of the Faculty of Medicine Universitas Indonesia on March 23, 2020 (No. KET-339/UN2.F1/ETIK/PPM.00.02/2020).


The characteristics of the 132 participants included in our study are outlined in Table 1. Our study population was vegetable farmers with a mean age of 49.9 years, consisting of 90.2% male and 86.3% with a low educational level (≤9 years of formal education). Our participants had been using pesticides for about 25 years, with a median frequency of spraying of 104 days per year. The median (minimum–maximum) CEL was 25.95 (1.28–136.58), and 48% of the participants were categorized as belonging to the high-CEL group. The urinary creatinine-adjusted TCPy levels were 2.31 (0.17–49.12) μg/g creatinine.
CYP2B6*6 gene polymorphisms were common in our study population, with a distribution of 31.1% for the *1/*1 genotype, 50.8% for *1/*6, and 18.2% for *6/*6, with no significant difference based on sex or CEL groups (Table 2). The minor allele frequencies of CYP2B6 785A>G and 516G>T were the same, at 43.9%.
The median TCPy level was significantly associated with CYP2B6, smoking habits, spraying time, and the use of additional pesticides to CPF, as described in Table 3.
Simple linear regression was performed to analyze the associations between TCPy levels and contributing factors (Supplemental Material 6). Following the stepwise procedure, all determinants associated with TCPy at a significance level of 0.05 (i.e., CYP2B6*6, smoking habits, body mass index (BMI), CEL and spraying time) were retained (Table 4). TCPy levels were higher among participants with the CYP2B6*1/*1 genotype (p=0.002) and high CEL (p=0.012), as well as among those who sprayed at other times than the morning (p=0.014). In contrast, smokers and those with a high BMI had lower TCPy levels.


The present study focused on determining the associations of the most prevalent and important CYP2B6 variants with CPF exposure. The most clinically relevant polymorphism of CYP2B6 was CYP2B6*6, with a co-occurrence of CYP2B6 785A>G and 516G>T) [23]. The CYP2B6*6 variant is common due to the strong linkage disequilibrium between the 516G>T and the 785A>G variants [24]. Our findings indicate that CYP2B6*6 gene polymorphisms were present in two-thirds of our study population, and the observed frequency of the CYP2B6*6 genotype was in Hardy-Weinberg equilibrium. The minor allele frequencies of CYP2B6 516G>T and the 785A>G among our participants were higher than those reported in Egyptian [25], Turkish [26], and Han Chinese [27] populations.
CPF is eliminated from the body primarily in the urine, with a relatively short biological half-life of approximately 27 hours [9]. The detection rate of urinary TCPy, a specific metabolite of CPF, in our study was 100%. Although measurement of urinary TCPy as a biomarker of CPF exposure is an established method to study CPF exposure and reflects all exposure pathways, finding a measurable amount of urinary TCPy does not necessarily mean it will cause adverse health effects, as urinary TCPy levels provide only limited evidence of exposure [28]. The urinary TCPy levels in our study populations were similar to those in previous studies in the general population [29,30]. Nevertheless, compared to other studies among populations that were extensively exposed to CPF, our results are far lower [11,31]. We suggest that differences in the nature of exposure (i.e., pesticide concentrations, application methods, or climate conditions) may contribute to these results.
We observed in the present study that farmers who used >2 additional pesticides had higher TCPy levels. We assumed that this practice might be associated with a tendency to use CPF beyond the recommended dose, thereby increasing the chemical uptake and resulting in higher TCPy levels. The practice of using multiple pesticides also raises concerns regarding the possibility that interactions of CPF with other pesticides may increase the potential for toxicity [32]. We found that CYP2B6*6, smoking status, BMI, CEL, and spraying time were associated with urinary TCPy levels. CYP2B6 is known as a prominent catalyst in CPF bioactivation; thus, this result indicates significantly higher CPF-O formation [33]. In particular, CYP2B6*6 has similar kinetic activity to that of CYP2B6*1, but it is expressed at lower levels due to the aberrant splicing [34], thereby reducing its ability to activate CPF-O formation [14]. The presence of genetic variations in human CYP may influence (favorably or unfavorably) the susceptibility to potential health impacts on those exposed to xenobiotics [7,35]. Since CYP2B6 is one of the most important enzymes in CPF metabolism, individuals with higher CYP2B6 expression (i.e., CYP2B6*1/*1) are more susceptible to exposure due to the higher formation of CPF-O, as further indicated by higher TCPy levels [33]. This finding is supported by the fact that the *1/*6 group also had higher TCPy levels than the *6/*6 group. In addition, there were no significant differences in genotype distribution according to sex or CEL, suggesting that the members of both groups shared similar genetic susceptibility to CPF exposure.
The farmers in this study seemed to have had a long history of pesticide use, as they had spent most of their lives in the profession of farming and their agricultural practices had been applied over many years. This finding explains why the high CEL group in our study was characterized by a low frequency of PPE utilization and poor work practices [17], and had higher TCPy levels. Urinary TCPy levels were significantly lower in smokers than in non-smokers; a similar pattern was found in previous research [36,37]. Though the actual mechanism remains unclear, tobacco smoking is thought to modify the physiological transformation and metabolism of xenobiotics, including OP pesticides [38]. The highest CPF concentrations are present in fat or adipose tissue, leading to the speculation that lipid storage may play an important role in the rate of CPF elimination. CPF that is temporarily bound to fat tissue will be released and undergo bioactivation, potentially resulting in a longer-lasting effect [39]. The spraying time refers to the time of application or the time when farmers spray pesticides on their crops. In the morning, the air is more likely to be calm than at other times of day, reducing the risk of chemicals being accidentally inhaled due to high winds. Furthermore, the lower temperatures and relatively high humidity in the morning may mean that the sprayed pesticides do not evaporate, reducing the potential for spray drift that could lead to unnecessary inhalation exposure; thus, spraying in the morning may be useful for personal protection [40].
Farmers, particularly those in the small-scale sector, with limited knowledge of proper pesticide handling practices may not be aware that they are susceptible to the health impacts of CPF exposure [17]. Deleterious effects of pesticides are not determined solely by genetic susceptibility; therefore, exposure control through comprehensive preventive measures (i.e., providing proper knowledge of the potential health impacts of pesticide exposure and training on pesticide handling and utilization of proper PPE) must be considered.
Our study had some limitations. The exact amount of CPF and the composition of the mixtures used were not directly measured, and since all information regarding agricultural activities was self-reported, the exposure estimates may have been misclassified randomly. Therefore, to limit the possibility of misclassification, we randomly asked several important questions to determine the consistency of the answers. Exposure to CPF may also arise from consuming contaminated food or drink; however, information on dietary intake was not collected. In addition, although the participants were asked to attend the second phase within the specified time (1 day after spraying activities), in some cases they attended at different times according to their availability, which could affect the detected metabolites.
To the best of our knowledge, this is the first epidemiological study to report the frequency distribution of CYP2B6*6 gene polymorphisms in association with TCPy and its role in CPF toxicity in an Indonesian agricultural population. Despite its limitations, the results suggest that CYP2B6*6 may play an important role in reducing the susceptibility to CPF exposure. We found that CYP2B6*6 gene polymorphisms, together with CEL, smoking, BMI, and spraying time were determinants of urinary TCPy levels, as a biomarker of CPF toxicity. The CYP2B6*6 genotype is a potential biomarker of susceptibility to CPF exposure; thus, it will be useful in preventive measures or exposure management strategies among susceptible farming populations. Our results may warrant further investigation; in particular, a longitudinal study is needed to evaluate the influence of the CYP2B6*6 gene polymorphism on CPF metabolism, particularly among the agricultural population in Indonesia, to reduce potential health impacts.


The funders had no role in the design of the study, in the collection, analysis, and interpretation of data, or in the writing of the manuscript and the decision to publish.


The authors have no conflicts of interest associated with the material presented in this paper.


The authors received financial support for the research and publication of this article from Universitas Indonesia through PUTI Grant (No. NKB-4085/UN2.RST/HKP.05.00/2020) and Prodia Group.


Conceptualization: Liem JF, Suryandari DA, Malik SG, Mansyur M, Soemarko DS, Kekalih A, Subekti I, Suyatna FD, Pangaribuan B. Data curation: Liem JF. Formal analysis: Liem JF, Mansyur M. Funding acquisition: Liem JF, Suryandari DA. Methodology: Liem JF, Suryandari DA, Malik SG, Malik SG, Mansyur M, Soemarko DS, Kekalih A, Subekti I, Suyatna FD, Pangaribuan B. Writing – original draft: Liem JF, Suryandari DA. Writing – review and editing: Suryandari DA, Malik SG, Mansyur M, Soemarko DS, Kekalih A, Subekti I, Suyatna FD, Pangaribuan B.

Table 1
Characteristics of the study population (n=132)
Characteristics Description
Age (y) 49.9±9.5
Body mass index (kg/m2) 22.9±2.9
Male 119 (90.2)
Low level of education 114 (86.3)
Smoking 65 (49.2)
Member of farmers’ society 123 (93.2)
Intensity level 11.8 (1.0–23.0)
Lifetime years of pesticide use (y) 25 (1–45)
No. of days spraying per year (day) 104 (37–364)
Cumulative exposure level (×103) 25.95 (1.28–136.58)
Post-spraying days (day) 1 (1–10)
Arable land area (acres) 0.20 (0.01–0.70)
Daily work duration (hr) 6 (3–10)
Duration of spraying pesticide (hr/day) 0.43 (0.04–2.25)
Volume of the mixture applied (L/day) 19.7 (2.3–85.0)

Values are presented as mean±standard deviation or number (%) or median (minimum–maximum).

Table 2
Distribution of CYP2B6 genotype according to the sex group and CEL
Genotype All (n=132) Sex CEL

Male (n=119) Female (n=13) p-value1 High (n=63) Low (n=69) p-value1
CYP2B6*6 0.882 0.328
*1/*1 41 (31.1) 37 (31.1) 4 (30.8) 21 (33.3) 20 (29.0)
*1/*6 67 (50.8) 61 (51.3) 6 (46.2) 28 (44.4) 39 (56.5)
*6/*6 24 (18.2) 21 (17.6) 3 (13.0) 14 (22.2) 10 (14.5)

Values are presented as number (%).

CEL, cumulative exposure level (low: ≤25.9; high: >25.9).

1 From chi-square test.

Table 3
Comparison of TCPy concentrations of the study population grouped according to the CYP2B6*6 genotype, socio-demographic, and occupational characteristics
Variables n TCPy1 p-value2
*1/*1 41 4.53 (0.39–49.12) 0.0053,4
*1/*6 67 2.21 (0.53–22.22)
*6/*6 24 1.66 (0.17–20.74)

 Female 13 2.08 (0.56–30.31) 0.601
 Male 119 2.35 (0.17–49.12)

Smoking status
 Smoking 65 1.63 (0.17–42.64) <0.001
 Not smoking 67 3.68 (0.39–49.12)

Spraying time
 Other than morning 47 4.97 (0.17–42.64) <0.001
 Morning time 85 1.78 (0.39–49.12)

Type of knapsack sprayer
 Manual pressurized 30 2.34 (0.17–49.12) 0.942
 Motorized 102 2.31 (0.39–30.61)

Additional pesticides to CPF
 >2 pesticides 35 4.28 (0.17–42.64) 0.005
 ≤2 pesticides 97 1.79 (0.39–49.12)

Direct contact with pesticides
 Frequent 95 2.35 (0.39–49.12) 0.897
 Rare/never 37 2.12 (0.17–42.64)

Cumulative exposure level
 High 63 2.63 (0.53–49.12) 0.343
 Low 69 2.12 (0.17–42.64)

TCPy, 3,5,6-trichloro-2-pyridinol; CYP, cytochrome P450; CPF, chlorpyrifos.

1 Median (minimum–maximum) in μg/g creatinine.

2 From Mann-Whitney test.

3 From Kruskal Wallis test.

4 Post-hoc testing with the Mann-Whitney U test between *1/*1 to *1/*6 and *6/*6 showed significant differences, at p=0.039 and p=0.002, respectively.

Table 4
Multiple linear regression analysis of the association between TCPy and contributing factors1
Variables2 B SE (B) Beta 95% CI for B p-value
Constant 22.61 4.82 - 13.08 32.15 <0.001
CYP2B6*6 −2.66 0.86 −0.24 −4.36 −0.95 0.002
Smoking 3.61 1.24 0.24 1.17 6.05 0.004
BMI −0.57 0.21 −0.22 −0.98 −0.16 0.006
CEL −3.11 1.22 −0.20 −5.52 −0.70 0.012
Spraying time −3.21 1.28 −0.20 −5.74 −0.67 0.014

TCPy, 3,5,6-trichloro-2-pyridinol; B, parameter estimate; SE (B), standard error for B; CI, confidence interval; LL, lower limit; UL, upper limit; CYP, cytochrome P450; BMI, body mass index; CEL, cumulative exposure level.

1 R2 =0.243; Adjusted R2=0.213.

2 CYP2B6: *1/*1 (reference) or *1/*6 or *6/*6; Smoking status: smoking (reference) or not smoking; BMI in kg/m2 (continuous variable); CEL: high (reference) or low; Spraying time: other than morning (reference) or morning time.


1. Casida JE, Bryant RJ. The ABCs of pesticide toxicology: amounts, biology, and chemistry. Toxicol Res (Camb) 2017;6(6):755-763.
crossref pmid pmc pdf
2. Khan K, Ismail AA, Abdel Rasoul G, Bonner MR, Lasarev MR, Hendy O, et al. Longitudinal assessment of chlorpyrifos exposure and self-reported neurological symptoms in adolescent pesticide applicators. BMJ Open 2014;4(3):e004177.
crossref pmid pmc
3. Ventura C, Nieto MR, Bourguignon N, Lux-Lantos V, Rodriguez H, Cao G, et al. Pesticide chlorpyrifos acts as an endocrine disruptor in adult rats causing changes in mammary gland and hormonal balance. J Steroid Biochem Mol Biol 2016;156: 1-9.
crossref pmid
4. Shrestha S, Parks CG, Goldner WS, Kamel F, Umbach DM, Ward MH, et al. Pesticide use and incident hypothyroidism in pesticide applicators in the agricultural health study. Environ Health Perspect 2018;126(9):97008.
crossref pmid pmc
5. Damalas CA, Koutroubas SD. Farmers’ exposure to pesticides: toxicity types and ways of prevention. Toxics 2016;4(1):1.
crossref pmid pmc
6. Kim KH, Kabir E, Jahan SA. Exposure to pesticides and the associated human health effects. Sci Total Environ 2017;575: 525-535.
crossref pmid
7. Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology--with emphasis on cytochrome P450. Toxicol Sci 2011;120(1):1-13.
crossref pmid
8. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013;138(1):103-141.
crossref pmid
9. Testai E, Buratti FM, Consiglio ED. Chlorpyrifos. In: Krieger R, editor. Hayes’ handbook of pesticide toxicology. 3rd ed. London: Academic Press; 2010. p. 1505-1526.
10. Rendic SP, Guengerich FP. Human family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update. Arch Toxicol 2021;95(2):395-472.
crossref pmid pmc pdf
11. Farahat FM, Ellison CA, Bonner MR, McGarrigle BP, Crane AL, Fenske RA, et al. Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers. Environ Health Perspect 2011;119(6):801-806.
crossref pmid pmc
12. Callahan CL, Hamad LA, Olson JR, Ismail AA, Abdel-Rasoul G, Hendy O, et al. Longitudinal assessment of occupational determinants of chlorpyrifos exposure in adolescent pesticide workers in Egypt. Int J Hyg Environ Health 2017;220(8):1356-1362.
crossref pmid pmc
13. Zanger UM, Klein K. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet 2013;4: 24.
crossref pmid pmc
14. Crane AL, Klein K, Zanger UM, Olson JR. Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism. Toxicology 2012;293(1–3):115-122.
crossref pmid pmc
15. LeBeau AL, Johnson GT, McCluskey JD, Harbison RD. Evaluation of urinary pesticide biomarkers among a sample of the population in the United States. J Clinic Toxicol 2012;S5: 003.
16. Dosemeci M, Alavanja MC, Rowland AS, Mage D, Zahm SH, Rothman N, et al. A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. Ann Occup Hyg 2002;46(2):245-260.
17. Liem JF, Mansyur M, Soemarko DS, Kekalih A, Subekti I, Suyatna FD, et al. Cumulative exposure characteristics of vegetable farmers exposed to chlorpyrifos in Central Java - Indonesia; a cross-sectional study. BMC Public Health 2021;21(1):1066.
crossref pmid pmc pdf
18. Zakeri S, Amiri N, Pirahmadi S, Dinparast Djadid N. Genetic variability of CYP2B6 polymorphisms in southeast Iranian population: implications for malaria and HIV/AIDS treatment. Arch Iran Med 2014;17(10):685-691.
19. Smith JN, Wang J, Lin Y, Timchalk C. Pharmacokinetics of the chlorpyrifos metabolite 3,5,6-trichloro-2-pyridinol (TCPy) in rat saliva. Toxicol Sci 2010;113(2):315-325.
crossref pmid
20. Centers for Disease Control and Prevention. Urinary pyrethroids, herbicides, and OP metabolites in urine NHANES 2007–2008. Method No: 6103, 03 [cited 2021 Dec 1]. Available from: https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/labmethods/uphopm_e_met.pdf .

21. Martinez-Moral MP, Kannan K. How stable is oxidative stress level? An observational study of intra- and inter-individual variability in urinary oxidative stress biomarkers of DNA, proteins, and lipids in healthy individuals. Environ Int 2019;123: 382-389.
crossref pmid pmc
22. Zhu H, Kannan K. Inter-day and inter-individual variability in urinary concentrations of melamine and cyanuric acid. Environ Int 2019;123: 375-381.
crossref pmid pmc
23. Hedrich WD, Hassan HE, Wang H. Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B 2016;6(5):413-425.
crossref pmid pmc
24. Helsby NA, Yong M, van Kan M, de Zoysa JR, Burns KE. The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes. Br J Clin Pharmacol 2019;85(9):1925-1934.
crossref pmid pmc pdf
25. Ellison CA, Abou El-Ella SS, Tawfik M, Lein PJ, Olson JR. Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers. J Toxicol Environ Health A 2012;75(4):232-241.
crossref pmid pmc
26. Yuce-Artun N, Kose G, Suzen HS. Allele and genotype frequencies of CYP2B6 in a Turkish population. Mol Biol Rep 2014;41(6):3891-3896.
crossref pmid pdf
27. Guan S, Huang M, Chan E, Chen X, Duan W, Zhou SF. Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese. Eur J Pharm Sci 2006;29(1):14-21.
crossref pmid
28. Norén E, Lindh C, Rylander L, Glynn A, Axelsson J, Littorin M, et al. Concentrations and temporal trends in pesticide biomarkers in urine of Swedish adolescents, 2000–2017. J Expo Sci Environ Epidemiol 2020;30(4):756-767.
crossref pmid pmc pdf
29. Meeker JD, Barr DB, Ryan L, Herrick RF, Bennett DH, Bravo R, et al. Temporal variability of urinary levels of nonpersistent insecticides in adult men. J Expo Anal Environ Epidemiol 2005;15(3):271-281.
crossref pmid pdf
30. Wang L, Liu Z, Zhang J, Wu Y, Sun H. Chlorpyrifos exposure in farmers and urban adults: metabolic characteristic, exposure estimation, and potential effect of oxidative damage. Environ Res 2016;149: 164-170.
crossref pmid
31. Garabrant DH, Aylward LL, Berent S, Chen Q, Timchalk C, Burns CJ, et al. Cholinesterase inhibition in chlorpyrifos workers: characterization of biomarkers of exposure and response in relation to urinary TCPy. J Expo Sci Environ Epidemiol 2009;19(7):634-642.
crossref pmid pdf
32. Leemans M, Couderq S, Demeneix B, Fini JB. Pesticides with potential thyroid hormone-disrupting effects: a review of recent data. Front Endocrinol (Lausanne) 2019;10: 743.
crossref pmid pmc
33. Foxenberg RJ, Ellison CA, Knaak JB, Ma C, Olson JR. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion. Toxicology 2011;285(1–2):57-66.
crossref pmid pmc
34. Hofmann MH, Blievernicht JK, Klein K, Saussele T, Schaeffeler E, Schwab M, et al. Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver. J Pharmacol Exp Ther 2008;325(1):284-292.
crossref pmid
35. Teodoro M, Briguglio G, Fenga C, Costa C. Genetic polymorphisms as determinants of pesticide toxicity: recent advances. Toxicol Rep 2019;6: 564-570.
crossref pmid pmc
36. Llop S, Murcia M, Iñiguez C, Roca M, González L, Yusà V, et al. Distributions and determinants of urinary biomarkers of organophosphate pesticide exposure in a prospective Spanish birth cohort study. Environ Health 2017;16(1):46.
crossref pmid pmc pdf
37. Li AJ, Chen Z, Lin TC, Buck Louis GM, Kannan K. Association of urinary metabolites of organophosphate and pyrethroid insecticides, and phenoxy herbicides with endometriosis. Environ Int 2020;136: 105456.
crossref pmid pmc
38. Lee S, Poet TS, Smith JN, Busby-Hjerpe AL, Timchalk C. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats. Chem Biol Interact 2010;184(3):449-457.
crossref pmid
39. Eaton DL, Daroff RB, Autrup H, Bridges J, Buffler P, Costa LG, et al. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit Rev Toxicol 2008;38(Suppl 2):1-125.
crossref pmid
40. National Pesticide Information Center. Pesticide vapor pressure topic fact sheet. 2016. [cited 2021 Dec 1]. Available from: http://npic.orst.edu/factsheets/vaporpressure.html .

Editorial Office
#203, 92 Wangsan-ro, Dongdaemun-gu, Seoul 02585, Korea
Tel : +82-2-740-8328   Fax : +82-2-764-8328   E-mail: jpmph@prevmed.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © 2022 by Korean Society for Preventive Medicine.                 Developed in M2PI